COVID-19 presents unprecedented challenges for the MedTech industry. Read on to discover some of the most striking R&D changes in the new MedTech market, and the strategies that will drive tomorrow’s innovation.
Demand for diagnostic tests, Personal Protection Equipment, and critical medical supplies is skyrocketing. Healthcare requirements are shifting: off-site clinical trials, telemedicine, and remote medical treatment are rapidly becoming the new normal. MedTech organizations are racing to adapt to the new, disrupted landscape of healthcare.
With changing regulatory frameworks, increased stakes from the public sector, and new interest from private investors, savvy executives are redesigning the value chain end-to-end to thrive in this new environment.
Demand for diagnostic tests, Personal Protection Equipment, and critical medical supplies is skyrocketing. Healthcare requirements are shifting: off-site clinical trials, telemedicine, and remote medical treatment are rapidly becoming the new normal. MedTech organizations are racing to adapt to the new, disrupted landscape of healthcare.
With changing regulatory frameworks, increased stakes from the public sector, and new interest from private investors, savvy executives are redesigning the value chain end-to-end to thrive in this new environment.
